Skip to main content

Table 1 Basic patient characteristics

From: Markers of vitality in ovaries of transmen after long-term androgen treatment: a prospective cohort study

Parameter Median (IQR) Minimum-maximum
Age (years) 24.3 (20.7;32.0) 18.4–37.0
BMI (kg/m2) 23.4 (22.0;26.6) 20.4–30.5
Duration of testosterone treatment (months) 16.8 (12.1;24.0) 12.0–38.4
FSH (mU/mL) 4.9 (2.6;6.5) 1.2–7.6
LH (mU/mL) 2.6 (1.0;10.8) 0.0–25.8
Estradiol (pg/mL) 39 (33;55) 19–170
Total testosterone (ng/mL) 5.18 (4.46;6.16) 2.88–9.08
SHBG (nmol/L) 34.1 (23.4;38.9) 14.3–50.0
Bioavailable testosterone (ng/mL) 2.69 (1.96;3.38) 1.54–4.30